Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.2900 (-0.22%) ($42.2900 - $42.2900) on Thu. Aug. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.44% (three month average) | RSI | 34 | Latest Price | $42.2900(-0.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.4% a day on average for past five trading days. | Weekly Trend | HALO declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(42%) IWM(36%) IWO(36%) IFRA(35%) IWN(35%) | Factors Impacting HALO price | HALO will decline at least -1.22% in a week (0% probabilities). VIXM(-13%) UUP(-8%) VXX(-6%) TBT(-5%) USO(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.22% (StdDev 2.44%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.58(-22.96%) | Resistance Level | $44.26 | 5 Day Moving Average | $42.3(-0.02%) | 10 Day Moving Average | $42.84(-1.28%) | 20 Day Moving Average | $44.26(-4.45%) | To recent high | -18.4% | To recent low | 0.8% | Market Cap | $5.78b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |